Fierce Pharma
SEPTEMBER 9, 2024
With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing facility in its home country. The U.K. | With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing facility in its home country.
MedCity News
SEPTEMBER 9, 2024
Losing these retail medication outlets creates more than just pharmacy deserts. In many low-income and underserved areas, drugstores also serve as grocery stores and hubs for essential services, and hence their closures mean communities lose crucial access points for a variety of goods and services. The post There is Still a Significant Need for Community Pharmacies appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 9, 2024
Three months on, Eli Lilly has closed the books on its search for a new chief financial officer. And as with its previous CFO, Anat Ashkenazi, the company didn’t have to look far. | Lilly on Monday revealed that it’s slotting 23-year company veteran Lucas Montarce into the finance chief role after the pharma’s previous CFO, Anat Ashkenazi, announced her departure in early June.
MedCity News
SEPTEMBER 9, 2024
The weight loss results for the Terns Pharmaceuticals drug TERN-601 come from a four-week Phase 1 clinical trial. Terns is one of several companies developing oral GLP-1 obesity medications that could become alternatives to currently available injectable products from this drug class. The post Terns Pharma Oral GLP-1 Drug Leads to Greater Than 5% Weight Loss in Small Study appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
SEPTEMBER 9, 2024
After opting out of Teva’s $4.25 billion national opioid settlement last year, the city of Baltimore has secured its own payout through a settlement deal worth $80 million. | The city scored its own deal after opting not to join in on Teva's $4.25 billion national opioid settlement.
MedCity News
SEPTEMBER 9, 2024
In an age where consumers have more options than ever about where to receive their care, improving the financial experience through embedded finance can give providers an advantage in an increasingly competitive marketplace. The post How Embedded Finance Creates a Better Patient Experience appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
SEPTEMBER 9, 2024
The American Medical Association released a new report on Monday on pharmacy benefit managers. It explained that there is low competition among PBMs and high vertical integration with payers. The post AMA Report Details Low Competition in PBM Market appeared first on MedCity News.
pharmaphorum
SEPTEMBER 9, 2024
Summit Therapeutics and Akeso's ivonescimab tops Merck's Keytruda in head-to-head phase 3 trial in first-line NSCLC, reported at WCLC.
MedCity News
SEPTEMBER 9, 2024
At a recent conference, Maria Berkman — who serves as head of medtech at Broadview Ventures and managing director at Longview Ventures — shared insights into the somewhat niche ecosystem of medtech investment. The post 3 Things to Know About Medtech Investment, From a VC appeared first on MedCity News.
Pharmaceutical Commerce
SEPTEMBER 9, 2024
In the second part of her interview with Pharma Commerce Editor Nicholas Saraceno, Meghan Mullooly, Archbow Consulting’s Vice President, offers advice to pharma manufacturers for successfully applying digital solutions to their patient support programs.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
SEPTEMBER 9, 2024
A report from Frontier Economics has highlighted the major benefit industry clinical trials have had on UK’s economy. For instance, it has supported its growth and the job market, the research showed. Of the 65,000 jobs generated, 21,000 individuals were employed directly by the pharmaceutical industry to deliver trials, according to the data. While industry clinical trials in the UK have reduced , the Association of the British Pharmaceutical Industry (ABPI) stated that if the activity assumes
PharmaVoice
SEPTEMBER 9, 2024
The deal, which targets metabolic diseases, is one of a few by Big Pharma to develop lncRNA therapies.
pharmaphorum
SEPTEMBER 9, 2024
AI biomarker could help identify lung cancer patients most likely to benefit from AstraZeneca and Daiichi Sankyo's TROP2 drug Dato-DXd.
Pharmaceutical Commerce
SEPTEMBER 9, 2024
The latest news for pharma industry insiders.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PharmaTimes
SEPTEMBER 9, 2024
Research suggests that LLMs could be used to support trainee doctors, nurses and GPs
pharmaphorum
SEPTEMBER 9, 2024
NICE backs NHS of MSD's Welireg for cancers associated with von Hippel-Lindau (VHL) disease after earlier rejection
Pharmaceutical Technology
SEPTEMBER 9, 2024
CC-115 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Solid Tumor.
PharmaTech
SEPTEMBER 9, 2024
CDER’s Jonathan Chapman, senior policy advisor, and Takeda’s Paulien Groll, head of Compliance Excellence, discussed how companies can be proactive with their CAPA strategies instead of reactive, at the 2024 PDA/FDA Joint Regulatory Conference.
Pharmaceutical Technology
SEPTEMBER 9, 2024
Ifetroban is under clinical development by Cumberland Pharmaceuticals and currently in Phase II for Asthma.
pharmaphorum
SEPTEMBER 9, 2024
House of Representatives votes in favour of BIOSECURE Act, which will stop businesses in the US from contracting with Chinese firms on national security grounds
Pharmaceutical Technology
SEPTEMBER 9, 2024
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Merkel Cell Carcinoma.
MedCity News
SEPTEMBER 9, 2024
Any successful response to skyrocketing drug costs has to also actively manage medications at the individual level — just because someone can be on a medication doesn’t mean they should be. The post It’s Time to Actively Manage Medications at the Individual Level appeared first on MedCity News.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Technology
SEPTEMBER 9, 2024
Venetoclax is under clinical development by AbbVie and currently in Phase III for Mantle Cell Lymphoma.
Pharmacy Times
SEPTEMBER 9, 2024
Presenter Krish Patel, MD, discusses the use of epcoritamab (Epkinly; AbbVie) and glofitamab (Columvi; Genentech) in aggressive B-cell lymphomas as monotherapies and in combination regimens.
Pharmaceutical Technology
SEPTEMBER 9, 2024
Envafolimab is under clinical development by Alphamab Oncology and currently in Phase II for Papillary Thyroid Cancer.
Impetus Digital
SEPTEMBER 9, 2024
Our client, a leader in the endocrinology sector, faced the challenge of launching a product in new indications without established treatment guidelines. To navigate this complex scenario, they turned to Impetus Digital’s innovative virtual platform and strategic experts. Through a combination of asynchronous data reviews, insight-gathering, patient journey mapping, and treatment pathway profiling plus real-time virtual Scientific Workshops , the endocrinology KOLs were able to reach a consensus
PharmaTech
SEPTEMBER 9, 2024
Webinar Date/Time: Wed, Oct 2, 2024 9:00 AM EDT
Spotio
SEPTEMBER 9, 2024
Short for revenue operations, RevOps is the alignment of Marketing, Sales, and Support functions to improve the customer experience and increase revenue growth. RevOps is important because it helps connect internal teams, drive consistent revenue growth, increase customer happiness and retention, and boost company-wide efficiency metrics. In other words, RevOps will help your organization do what it does more effectively.
PharmaTech
SEPTEMBER 9, 2024
In this paper, the authors introduce a method that combines ion exchange chromatography with an easier-to-perform, simpler one-step post-column derivatization that is selective to nitrite and visible spectrophotometric detection to allow high sample loading volumes without affecting resolution.
Pharmaceutical Technology
SEPTEMBER 9, 2024
Alpha-1 proteinase inhibitor (human) second generation is under clinical development by Kamada Pharmaceuticals and currently in Phase II for Alpha-1…
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
247 
Let's personalize your content